SC 13D/A 1 tm2418964d1_sc13da.htm SC 13D/A

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 8)*

 

R1 RCM INC.

(Name of Issuer)

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

77634L 105

(CUSIP Number)

 

Glenn Miller

c/o TowerBrook Capital Partners L.P.

Park Avenue Tower

65 East 55th Street, 19th Floor

New York, NY 10022

(212) 699-2200

 

Copy to:

Steven A. Cohen

Victor Goldfeld

Wachtell, Lipton, Rosen & Katz

51 West 52nd Street

New York, NY 10019

(212) 403-1000

 

Christine McCoy

c/o Ascension Health Alliance

101 S. Hanley Road, Suite 450

St. Louis, MO 63105

(314) 733-8000

 

Copy to:

Stephen A. Infante

Covington & Burling LLP

620 Eighth Avenue

New York, NY 10018

(212) 841-1000

(Name, Address and Telephone Number of Persons
Authorized to Receive Notices and Communications)

 

July 5, 2024

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).

 

 

 

 

CUSIP No. 77634L 105

 

1. NAMES OF REPORTING PERSONS

TCP-ASC ACHI Series LLLP
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
 OO
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨
6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7. SOLE VOTING POWER
 
0
8. SHARED VOTING POWER
 
164,754,055 (1)
9. SOLE DISPOSITIVE POWER
 
0
10.

SHARED DISPOSITIVE POWER

 

164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1)
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

Common Stock:  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

PN

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

 

 

 

CUSIP No. 77634L 105
1. NAMES OF REPORTING PERSONS

TCP-ASC GP, LLC
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
 OO
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨
6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
  7. SOLE VOTING POWER
 
0
  8. SHARED VOTING POWER
 
164,754,055 (1)
  9. SOLE DISPOSITIVE POWER
 
0
  10. SHARED DISPOSITIVE POWER
 
164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1)
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

Common Stock:  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

OO

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

 

 

 

CUSIP No. 77634L 105
1. NAMES OF REPORTING PERSONS

TI IV ACHI Holdings GP, LLC
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
 OO
5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨

6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
  7. SOLE VOTING POWER
 
0
  8. SHARED VOTING POWER
 
164,754,055 (1)
  9. SOLE DISPOSITIVE POWER
 
0
  10. SHARED DISPOSITIVE POWER
 
164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1) (3)
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

Common Stock:  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

OO

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

(3) TI IV ACHI Holdings GP, LLC disclaims beneficial ownership of 75,889,325 shares of Common Stock held directly by Series AS (as defined in Item 6 herein).

 

 

 

CUSIP No. 77634L 105
1. NAMES OF REPORTING PERSONS

TI IV ACHI Holdings, LP
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
 OO
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨
6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   7. SOLE VOTING POWER
 
0
  8. SHARED VOTING POWER
 
164,754,055 (1)
  9. SOLE DISPOSITIVE POWER
 
0
  10. SHARED DISPOSITIVE POWER
 
164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1) (3)
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

Common Stock:  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

PN

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

(3) TI IV ACHI Holdings GP, LLC disclaims beneficial ownership of 75,889,325 shares of Common Stock held directly by Series AS (as defined in Item 6 herein).

 

 

 

CUSIP No. 77634L 105
1. NAMES OF REPORTING PERSONS

TowerBrook Investors Ltd.
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
 OO
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨
6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
Cayman Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
  7. SOLE VOTING POWER
 
0
  8. SHARED VOTING POWER
 
164,754,055  (1)
  9. SOLE DISPOSITIVE POWER
 
0
  10. SHARED DISPOSITIVE POWER
 
164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1) (3)
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

Common Stock:  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

OO

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

(3) TowerBrook Investors Ltd. disclaims beneficial ownership of 75,889,325 shares of Common Stock held directly by Series AS (as defined in Item 6 herein).

 

 

 

CUSIP No. 77634L 105
1. NAMES OF REPORTING PERSONS

Neal Moszkowski
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
 OO
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨
6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
U.S.A.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   7. SOLE VOTING POWER
 
0
  8. SHARED VOTING POWER
 
164,754,055 (1)
  9. SOLE DISPOSITIVE POWER
 
0
  10. SHARED DISPOSITIVE POWER
 
164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1) (3)
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

Common Stock  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

IN

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

(3) Neal Moszkowski disclaims beneficial ownership of 75,889,325 shares of Common Stock held directly by Series AS (as defined in Item 6 herein).

 

 

 

CUSIP No. 77634L 105
1. NAMES OF REPORTING PERSONS

Jonathan Bilzin
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
 OO
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨
6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
U.S.A.

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
  7. SOLE VOTING POWER
 
0
  8. SHARED VOTING POWER
 
164,754,055 (1)
  9. SOLE DISPOSITIVE POWER
 
0
  10. SHARED DISPOSITIVE POWER
 
164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1) (3)
12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨

13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

Common Stock:  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

IN

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

(3) Jonathan Bilzin disclaims beneficial ownership of 75,889,325 shares of Common Stock held directly by Series AS (as defined in Item 6 herein).

 

 

 

CUSIP No. 77634L 105
1. NAMES OF REPORTING PERSONS

Karim Saddi
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
OO
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨
6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
France

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   7. SOLE VOTING POWER
 
 0
  8. SHARED VOTING POWER
 
164,754,055 (1)
  9.

SOLE DISPOSITIVE POWER

 

0

  10.

SHARED DISPOSITIVE POWER

 

164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1) (3)
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 Common Stock:  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

IN

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

(3) Karim Saddi disclaims beneficial ownership of 75,889,325 shares of Common Stock held directly by Series AS (as defined in Item 6 herein).

 

 

 

CUSIP No. 77634L 105
1. NAMES OF REPORTING PERSONS

ASCENSION HEALTH ALLIANCE
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)  x
(b)  ¨
3. SEC USE ONLY
 
4. SOURCE OF FUNDS (see instructions)
OO
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨
6. CITIZENSHIP OR PLACE OF ORGANIZATION
 
Missouri

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   7. SOLE VOTING POWER
 
 0
  8. SHARED VOTING POWER
 
164,754,055 (1)
  9.

SOLE DISPOSITIVE POWER

 

0

  10.

SHARED DISPOSITIVE POWER

 

164,754,055 (1)

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

Common Stock:  164,754,055 (1) (3)
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)     ¨
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 Common Stock:  35.7% (1) (2)
14. TYPE OF REPORTING PERSON (see instructions)

CO

 

(1) Consists of 124,289,200 shares of Common Stock and 40,464,855 shares of Common Stock issuable upon exercise of the Warrant.

(2) For purposes of calculating beneficial ownership of the Reporting Person, the total number of shares of Common Stock outstanding is based on (1) 421,255,230 shares of Common Stock outstanding as of May 6, 2024 as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2024 and (2) 40,464,855 shares of Common Stock issuable upon exercise of the Warrant (see Note 1).

(3) Ascension Health Alliance disclaims beneficial ownership of 88,864,730 shares of Common Stock held directly by Series TB (as defined in Item 6 herein).

 

 

 

This Amendment No. 8 to Schedule 13D (this “Amendment No. 8”) amends and supplements the statement on Schedule 13D jointly filed by TCP-ASC ACHI Series LLLP (the “Partnership”), TCP-ASC GP, LLC, TI IV ACHI Holdings GP, LLC, TI IV ACHI Holdings, LP, TowerBrook Investors Ltd., Neal Moszkowski, Jonathan Bilzin, Karim Saddi and Ascension Health Alliance d/b/a Ascension (the “Reporting Persons”) with the Securities Exchange Commission (the “Commission”) on June 21, 2022, as amended on September 13, 2022, October 3, 2023, February 6, 2024, March 11, 2024, May 7, 2024, June 3, 2024 and June 13, 2024 (as it may be amended from time to time, this “Statement”), relating to the common stock, $0.01 par value per share (the “Common Stock”), of R1 RCM Inc. (the “Issuer”). Initially capitalized terms used in this Amendment No. 8 that are not otherwise defined herein shall have the same meanings attributed to them in the Schedule 13D. Except as expressly provided herein, all Items of the Schedule 13D remain unchanged.

 

ITEM 4. Purpose of the Transaction.

 

Item 4 of the Schedule 13D is hereby amended by deleting the final sentence of the first paragraph added to Item 4 by Amendment No. 4 to the Schedule 13D filed on March 11, 2024 and Item 4 of the Schedule 13D is hereby amended and supplemented as follows:

 

CoyCo and the Partnership have ceased discussions regarding their potential pursuit of a Joint Transaction.

 

The Partnership is in the process of finalizing a proposal to acquire all of the outstanding shares of Common Stock that are not currently owned by the Partnership at a price per share higher than the proposal described in the standstill waiver request by CoyCo on July 1, 2024. The Partnership has submitted to the Issuer a request to waive the standstill obligations in the A&R Investor Rights Agreement to permit the Partnership to submit a proposal to the Issuer (the “July 5 Waiver Request”). The foregoing description of the July 5 Waiver Request is not intended to be complete and is qualified in its entirety by reference to the full text of the July 5 Waiver Request filed as Exhibit 7.12 hereto.

 

As previously disclosed, the Partnership and its affiliates are not interested in selling any shares of Common Stock that the Partnership holds to another party at this time. Ascension, TowerBrook and their respective affiliates do not intend to participate in the proposal described in the standstill waiver request by CoyCo on July 1, 2024.

 

Joseph Flanagan, a member of the Board of Directors and the former Chief Executive Officer of the Issuer, and the Reporting Persons are in discussions regarding the possibility of Mr. Flanagan serving in a senior executive capacity with the Issuer following a potential acquisition of the Issuer by the Reporting Persons. In the interim, Mr. Flanagan expects to assist the Reporting Persons in conducting due diligence on the Issuer. The Reporting Persons have not reached any agreement, arrangement or understanding with Mr. Flanagan regarding any potential transaction with the Issuer.

 

ITEM 7. Materials to be Filed as Exhibits.

 

The following document noted as Exhibit 7.12 is filed as an exhibit to this Statement:

 

Exhibit
Number
  Description of Exhibit
     
Exhibit 7.12   Waiver Request, dated July 5, 2024.

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  Date: July 5, 2024
   
  TCP-ASC ACHI SERIES LLLP
   
  By: TCP-ASC GP, LLC, its General Partner
   
  By: /s/ Glenn F. Miller
  Name: Glenn F. Miller
  Title: Vice President
   
   
  TCP-ASC GP, LLC
   
  By: /s/ Glenn F. Miller
  Name: Glenn F. Miller
  Title: Vice President
   
   
  TI IV ACHI Holdings GP, LLC
   
  By: /s/ Glenn F. Miller
  Name: Glenn F. Miller
  Title: Vice President

 

[Signature Page to 13D Amendment]

 

 

 

  TI IV ACHI Holdings, LP
   
  By: TI IV ACHI Holdings GP, LLC, its General Partner
   
  By: /s/ Glenn F. Miller
  Name: Glenn F. Miller
  Title: Vice President
   
   
  TOWERBROOK INVESTORS LTD.
   
  By: /s/ Neal Moszkowski
  Name: Neal Moszkowski
  Title: Director
   
   
  NEAL MOSZKOWSKI
   
/s/ Neal Moszkowski
  Neal Moszkowski
   
   
  JONATHAN BILZIN
   
  /s/ Jonathan Bilzin
 

Jonathan Bilzin

   
   
  KARIM SADDI
   
  /s/ Karim Saddi
  Karim Saddi

 

[Signature Page to 13D Amendment]

 

 

 

  ASCENSION HEALTH ALLIANCE
   
  By: /s/ Christine McCoy
  Name: Christine McCoy
  Title: Executive Vice President & General Counsel

 

[Signature Page to 13D Amendment]